-
Biopharmaceuticals: A Surge in Growth Amidst Global Pharmaceutical Dynamics
Jan , 17 2024
Biopharmaceuticals are drugs manufactured using biotechnology, typically involving biologics such as proteins, antibodies, vaccines, and other biological formulations. Despite synthetic pharmaceutical...
read more
-
High Potency API (HPAPI): A Comprehensive Exploration of Market Dynamics and Future Prospect
Jan , 17 2024
High Potency Active Pharmaceutical Ingredients (HPAPI) are a class of active pharmaceutical ingredients that can elicit biological responses and exert their effects at extremely low doses, typically i...
read more
-
Innovative High-Density Fermentation Process for Producing Ultra-High Purity NMN
Mar , 12 2024
The high-density fermentation process for producing ultra-high purity NMN (β-Nicotinamide Mononucleotide CAS No.: 1094-61-7) using nicotinamide riboside kinase (NRK) represents a groundbreaking approa...
read more
-
China announces anti-aging NMN human clinical trial results: the physiological age of the NMN supplement group was significantly reduced！
May , 10 2024
On the morning of April 27, LEGEND Vascular Symposium 2024 was grandly held in Shanghai. At the meeting, the unblinded results of the anti-aging β-Nicotinamide Mononucleotide (short for NMN) , a human...
read more
-
The global market of synthetic biology continues to grow
May , 23 2024
According to the "China Synthetic Biology Industry White Paper 2024", the global syntheticbiology market has grown from US$5.3 billion in 2018 to over US$17 billion in 2023, with anaverage annual grow...
read more
-
Breakthrough in Synthetic Biology: Enhanced NMN Production in Engineered E. coli
Nov , 13 2024
The collaborative efforts of the synthetic biology and microbial metabolic engineering teams at the Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, have led to a groundbrea...
read more
IPv6 network supported
English
中文
français
Deutsch
русский
español
português
العربية
日本語
한국의
Türkçe
